Back to News
Aug 8, 2025 4:10 PM

Earnings Outlook For Karyopharm Therapeutics

Karyopharm Therapeutics (NASDAQ:KPTI) is set to give its latest quarterly earnings report on Monday, 2025-08-11. Here's what investors need to know before the announcement.

Analysts estimate that Karyopharm Therapeutics will report an earnings per share (EPS) of $-3.86.

The announcement from Karyopharm Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's ...
Karyopharm Therapeutics KPTI is set to give its latest quarterly earnings report on Monday, 2025-08-11. Here's what investors need to know before the announcement.

Analysts estimate that Karyopharm Therapeutics will report an earnings per share (EPS) of $-3.86.

The announcement from Karyopharm Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Performance in Previous EarningsIn the previous earnings release, the company beat EPS by $0.32, leading to a 20.0% drop in the share price the following trading session.

Here's a look at Karyopharm Therapeutics's past performance and the resulting price change:

Quarter

Q1 2025

Q4 2024

Q3 2024

Q2 2024

EPS Estimate

-3.09

-4.05

-3.9

-4.5

EPS Actual

-2.77

-3.60

-3.9

-3

Price Change %

-20.0%

2.0%

5.0%

-3.0%

Stock PerformanceShares of Karyopharm Therapeutics were trading at $3.97 as of August 07. Over the last 52-week period, shares are down 67.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.